Hossein Assarzadeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hossein Assarzadeh has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Ar Davari
Dept. of Operative Dentistry, School of Dentistry, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
1 shared publicationE Ataei
Dept. of Operative Dentistry, School of Dentistry, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
1 shared publication- Malihe Karrabi
Dept. of Prosthodotics, Faculty of Dentistry Sabzevar University of Medical Sciences, Sabzevar, Iran
1 shared publication - Zahra Baghani
Department of Periodontics, Faculty of Dentistry, Sabzevar University of Medical Sciences, Sabzevar, Iran
1 shared publication
Latest Publications
- 22 December 2024
- Published by Springer Nature in Lasers in Medical Science
- Vol. 39 (1) , 1-12
Gingival crevicular fluid level of tumor necrosis factor-alpha as a valuable biomarker for estimation of the efficacy of adjunctive antimicrobial photodynamic therapy in stage II-IV periodontitis: a systematic review and meta-analysis
Purpose This systematic review and meta-analysis aimed to assess the gingival crevicular fluid (GCF) level of tumor necrosis factor-alpha (TNF-alpha) as a valuable inflammatory cytokine for estimation of the efficacy of adjunctive antimicrobial photodynamic therapy (aPDT) in stage II-IV periodontitis patients. Methods This review was conducted in accordance with the PRISMA statements, and registered in PROSPERO (CRD42022321211). An electronic search was conducted for articles comparing the efficacy of aPDT versus scaling and root planing (SRP) published up until June 2023. The mean GCF level of TNF-alpha and clinical attachment loss (CAL) with 95% confidence interval (CI) were pooled and compared between the groups using a random-effect model after 1–2, 4–5, 12–13, and ≥ 24 weeks. The I2 test was applied to assess the heterogeneity of the findings, and publication bias was evaluated by visual inspection of the funnel plot symmetry. Results Analysis of 11 studies indicated a significant difference in GCF level of TNF-alpha at the 1–2, 12–13 and ≥ 24-week follow-ups in patients treated with aPDT + SRP. However, at the 4–5-week follow-up, the results were significant in favor of the control group (mean difference = -0.17, 95% CI = -1.86–152, P < 0.00001). Conclusion Despite the limitations of the included studies, aPDT can decrease the GCF level of TNF-alpha inflammatory biomarker for a longer period of time than SRP alone in grade II-IV periodontitis. However, further investigations are required to assess the efficacy of higher frequency of aPDT applications.
- 22 December 2024
- Published by Springer Nature in Lasers in Medical Science
- Vol. 39 (1) , 1-12
Gingival crevicular fluid level of tumor necrosis factor-alpha as a valuable biomarker for estimation of the efficacy of adjunctive antimicrobial photodynamic therapy in stage II-IV periodontitis: a systematic review and meta-analysis
Purpose This systematic review and meta-analysis aimed to assess the gingival crevicular fluid (GCF) level of tumor necrosis factor-alpha (TNF-alpha) as a valuable inflammatory cytokine for estimation of the efficacy of adjunctive antimicrobial photodynamic therapy (aPDT) in stage II-IV periodontitis patients. Methods This review was conducted in accordance with the PRISMA statements, and registered in PROSPERO (CRD42022321211). An electronic search was conducted for articles comparing the efficacy of aPDT versus scaling and root planing (SRP) published up until June 2023. The mean GCF level of TNF-alpha and clinical attachment loss (CAL) with 95% confidence interval (CI) were pooled and compared between the groups using a random-effect model after 1–2, 4–5, 12–13, and ≥ 24 weeks. The I2 test was applied to assess the heterogeneity of the findings, and publication bias was evaluated by visual inspection of the funnel plot symmetry. Results Analysis of 11 studies indicated a significant difference in GCF level of TNF-alpha at the 1–2, 12–13 and ≥ 24-week follow-ups in patients treated with aPDT + SRP. However, at the 4–5-week follow-up, the results were significant in favor of the control group (mean difference = -0.17, 95% CI = -1.86–152, P < 0.00001). Conclusion Despite the limitations of the included studies, aPDT can decrease the GCF level of TNF-alpha inflammatory biomarker for a longer period of time than SRP alone in grade II-IV periodontitis. However, further investigations are required to assess the efficacy of higher frequency of aPDT applications.
- Open Access
- 1 September 2013
- Vol. 14 (3) , 136-145
Dentin Hypersensitivity: Etiology, Diagnosis and Treatment; A Literature Review
The objective of this review is to inform practitioners about dentin hypersensitivity (DH); to provide a brief overview of the diagnosis, etiology and clinical management of dentin hypersensitivity and to discuss technical approaches to relieve sensitivity. This clinical information is described in the context of the underlying biology.
- 1 September 2013
- Vol. 14 (3) , 136-145
Open AccessDentin Hypersensitivity: Etiology, Diagnosis and Treatment; A Literature Review
The objective of this review is to inform practitioners about dentin hypersensitivity (DH); to provide a brief overview of the diagnosis, etiology and clinical management of dentin hypersensitivity and to discuss technical approaches to relieve sensitivity. This clinical information is described in the context of the underlying biology.